Beena Kunheri

Dr. Beena Kunheri


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
KJKurian Joseph
Kurian Joseph
BBBen Burke
Ben Burke
AHAmr Heikal
Amr Heikal
EYEugene Yip
Eugene Yip
SMShannah Murland
Shannah Murland
BKBeena Kunheri
Beena Kunheri
Pancreatic ductal adenocarcinoma is one of the most aggressive tumours, with an estimated 5-year overall survival rate of 5% and median survival of 5–11 months. Approximately one third of patients die of complications due to local disease progression, especially among patients with borderline resectable or locally advanced disease; hence achieving local control is significant for improved survival outcomes. Stereotactic body radiotherapy (SBRT) allows safe and effective delivery of ablative doses of radiation and is associated with improved locoregional tumour control and progression free survival. Our article describes the rationale and the safe and effective delivery of Linac-based SBRT treatment for pancreatic cancer.